{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:13:24Z","timestamp":1780427604406,"version":"3.54.1"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.1093\/ndt\/gfl097","type":"journal-article","created":{"date-parts":[[2006,3,28]],"date-time":"2006-03-28T01:12:43Z","timestamp":1143508363000},"page":"1825-1832","source":"Crossref","is-referenced-by-count":49,"title":["Persistent T-cell activation and clinical correlations in patients with ANCA-associated systemic vasculitis"],"prefix":"10.1093","volume":"21","author":[{"given":"Smaragdi","family":"Marinaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Isabelle","family":"K\u00e4lsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Grimminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Breedijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Birck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm H","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fokko J","family":"van der Woude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benito A","family":"Yard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,3,27]]},"reference":[{"key":"key\n\t\t\t\t20171012172634_BIB1","doi-asserted-by":"crossref","unstructured":"van der Woude F, Rasmussen N, Lobatto S et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet1985; 1: 425\u2013429","DOI":"10.1016\/S0140-6736(85)91147-X"},{"key":"key\n\t\t\t\t20171012172634_BIB2","doi-asserted-by":"crossref","unstructured":"Falk R, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA1990; 87: 4115\u20134119","DOI":"10.1073\/pnas.87.11.4115"},{"key":"key\n\t\t\t\t20171012172634_BIB3","doi-asserted-by":"crossref","unstructured":"Rarok A, Limburg PC, Kallenberg CG. Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J Leukoc Biol2003; 74: 3\u201315","DOI":"10.1189\/jlb.1202611"},{"key":"key\n\t\t\t\t20171012172634_BIB4","doi-asserted-by":"crossref","unstructured":"Xiao H, Heeringa P, Hu P et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest2002; 110: 919\u2013921","DOI":"10.1172\/JCI0215918"},{"key":"key\n\t\t\t\t20171012172634_BIB5","doi-asserted-by":"crossref","unstructured":"Brouwer E, Stegeman CA, Hiutema MG, Limburg PC, Kallenberg CG. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin Exp Immunol1994; 98: 448\u2013453","DOI":"10.1111\/j.1365-2249.1994.tb05511.x"},{"key":"key\n\t\t\t\t20171012172634_BIB6","doi-asserted-by":"crossref","unstructured":"Cunningham M, Huang XR, Dowling JP, Tipping PG, Holdsworth SR. Prominence of cell-mediated immunity effectors in \u201cpauci-immune\u201d glomerulonephritis. J Am Soc Nephrol1999; 10: 499\u2013506","DOI":"10.1681\/ASN.V103499"},{"key":"key\n\t\t\t\t20171012172634_BIB7","doi-asserted-by":"crossref","unstructured":"Schmitt W, Heesen C, Csernok E, Rautmann A, Gross WL. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity. Arthritis Rheum1992; 35: 1088\u20131096","DOI":"10.1002\/art.1780350914"},{"key":"key\n\t\t\t\t20171012172634_BIB8","doi-asserted-by":"crossref","unstructured":"Wang G, Hansen H, Tatsis E, Csernok E, Lemke H, Gross WL. High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis. Am J Med1997; 102: 517\u2013523","DOI":"10.1016\/S0002-9343(97)00049-1"},{"key":"key\n\t\t\t\t20171012172634_BIB9","doi-asserted-by":"crossref","unstructured":"Lockwood C, Thiru S, Isaacs JD, Hale G, Waldmann H. Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy. Lancet1993; 341: 1620\u20131622","DOI":"10.1016\/0140-6736(93)90759-A"},{"key":"key\n\t\t\t\t20171012172634_BIB10","doi-asserted-by":"crossref","unstructured":"Schmitt W, Hagen EC, Neumann I, Nowack R, Flores-Suarez LF, van der Woude FJ; European Vasculitis Study Group. Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int2004; 65: 1440\u20131448","DOI":"10.1111\/j.1523-1755.2004.00534.x"},{"key":"key\n\t\t\t\t20171012172634_BIB11","doi-asserted-by":"crossref","unstructured":"Popa E, Stegeman CA, Bos NA, Kallenberg CG, Tervaert JW. Differential B- and T-cell activation in Wegener's granulomatosis. J Allergy Clin Immunol1999; 103: 885\u201389","DOI":"10.1016\/S0091-6749(99)70434-3"},{"key":"key\n\t\t\t\t20171012172634_BIB12","doi-asserted-by":"crossref","unstructured":"Popa E, Stegeman CA, Bos NA, Kallenberg CG, Tervaert JW. Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis. Clin Exp Immunol2003; 132: 496\u2013504","DOI":"10.1046\/j.1365-2249.2003.02157.x"},{"key":"key\n\t\t\t\t20171012172634_BIB13","doi-asserted-by":"crossref","unstructured":"Marinaki S, Neumann I, K\u00e4lsch A-I et al. Abnormalities of CD4\u2009T cell subpopulations in ANCA-associated vasculitis. Clin Exp Immunol2005; 140: 181\u2013191","DOI":"10.1111\/j.1365-2249.2005.02731.x"},{"key":"key\n\t\t\t\t20171012172634_BIB14","doi-asserted-by":"crossref","unstructured":"Vogt S, Iking-Konert C, Hug F, Andrassy K, Hansch GM. Shortening of telomeres: evidence for replicative senescence of T cells derived from patients with Wegener's granulomatosis. Kidney Int2003; 63: 2144\u20132151","DOI":"10.1046\/j.1523-1755.2003.00037.x"},{"key":"key\n\t\t\t\t20171012172634_BIB15","doi-asserted-by":"crossref","unstructured":"Lamprecht P, Vargas Cuero AL, Muller A et al. Alterations in the phenotype of CMV-specific and total CD8+ T-cell populations in Wegener's granulomatosis. Cell Immunol2003; 224: 1\u20137","DOI":"10.1016\/j.cellimm.2003.08.003"},{"key":"key\n\t\t\t\t20171012172634_BIB16","doi-asserted-by":"crossref","unstructured":"Schlesier M, Kaspar T, Gutfleisch J, Wolff-Vorbeck G, Peter HH. Activated CD4+ and CD8+ T-cell subsets in Wegener's granulomatosis. Rheumatol Int1995; 14: 213\u2013219","DOI":"10.1007\/BF00262300"},{"key":"key\n\t\t\t\t20171012172634_BIB17","doi-asserted-by":"crossref","unstructured":"Giscombe R, Nityanand S, Lewin N, Grunewald J, Lefvert AK. Expanded T cell populations in patients with Wegener's granulomatosis: characteristics and correlates with disease activity. J Clin Immunol1998; 18: 404\u2013413","DOI":"10.1023\/A:1023230722874"},{"key":"key\n\t\t\t\t20171012172634_BIB18","doi-asserted-by":"crossref","unstructured":"Stohne JH, Wegeners Granulomatosis Etanercept Trial Research Group. Limited versus Severe Wegener's Granulomatosis. Arthritis Rheum2003; 48: 2299\u20132309","DOI":"10.1002\/art.11075"},{"key":"key\n\t\t\t\t20171012172634_BIB19","doi-asserted-by":"crossref","unstructured":"Birck R, Schmitt WH, Kaelsch IA, van der Woude FJ. Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review. Am J Kidney Dis2006; 47: 15\u201323","DOI":"10.1053\/j.ajkd.2005.09.022"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/21\/7\/1825\/5156983\/gfl097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T06:18:34Z","timestamp":1627193914000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/21\/7\/1825\/1821903\/Persistent-Tcell-activation-and-clinical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,27]]},"references-count":19,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2006,3,27]]},"published-print":{"date-parts":[[2006,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfl097","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,7]]},"published":{"date-parts":[[2006,3,27]]}}}